260 related articles for article (PubMed ID: 25791065)
1. Emodin ameliorates high glucose induced-podocyte epithelial-mesenchymal transition in-vitro and in-vivo.
Chen T; Zheng LY; Xiao W; Gui D; Wang X; Wang N
Cell Physiol Biochem; 2015; 35(4):1425-36. PubMed ID: 25791065
[TBL] [Abstract][Full Text] [Related]
2. Overexpression of FOXO1 ameliorates the podocyte epithelial-mesenchymal transition induced by high glucose in vitro and in vivo.
Du M; Wang Q; Li W; Ma X; Wu L; Guo F; Zhao S; Huang F; Wang H; Qin G
Biochem Biophys Res Commun; 2016 Mar; 471(4):416-22. PubMed ID: 26902117
[TBL] [Abstract][Full Text] [Related]
3. Astragaloside IV ameliorates diabetic nephropathy involving protection of podocytes in streptozotocin induced diabetic rats.
Chen J; Chen Y; Luo Y; Gui D; Huang J; He D
Eur J Pharmacol; 2014 Aug; 736():86-94. PubMed ID: 24809932
[TBL] [Abstract][Full Text] [Related]
4. Panax Notoginseng Ameliorates Podocyte EMT by Targeting the Wnt/β-Catenin Signaling Pathway in STZ-Induced Diabetic Rats.
Xie L; Zhai R; Chen T; Gao C; Xue R; Wang N; Wang J; Xu Y; Gui D
Drug Des Devel Ther; 2020; 14():527-538. PubMed ID: 32103895
[TBL] [Abstract][Full Text] [Related]
5. Notoginsenoside R1 ameliorates podocyte adhesion under diabetic condition through α3β1 integrin upregulation in vitro and in vivo.
Gui D; Wei L; Jian G; Guo Y; Yang J; Wang N
Cell Physiol Biochem; 2014; 34(6):1849-62. PubMed ID: 25503068
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of integrin-linked kinase blocks podocyte epithelial-mesenchymal transition and ameliorates proteinuria.
Kang YS; Li Y; Dai C; Kiss LP; Wu C; Liu Y
Kidney Int; 2010 Aug; 78(4):363-73. PubMed ID: 20505657
[TBL] [Abstract][Full Text] [Related]
7. Schisandra chinensis fruit extract attenuates albuminuria and protects podocyte integrity in a mouse model of streptozotocin-induced diabetic nephropathy.
Zhang M; Liu M; Xiong M; Gong J; Tan X
J Ethnopharmacol; 2012 May; 141(1):111-8. PubMed ID: 22353431
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of TRPC6 Signal Pathway Alleviates Podocyte Injury Induced by TGF-β1.
Huang H; You Y; Lin X; Tang C; Gu X; Huang M; Qin Y; Tan J; Huang F
Cell Physiol Biochem; 2017; 41(1):163-172. PubMed ID: 28214865
[TBL] [Abstract][Full Text] [Related]
9. Swiprosin-1 Promotes Mitochondria-Dependent Apoptosis of Glomerular Podocytes via P38 MAPK Pathway in Early-Stage Diabetic Nephropathy.
Wang RM; Wang ZB; Wang Y; Liu WY; Li Y; Tong LC; Zhang S; Su DF; Cao YB; Li L; Zhang LC
Cell Physiol Biochem; 2018; 45(3):899-916. PubMed ID: 29421811
[TBL] [Abstract][Full Text] [Related]
10. The roles of connective tissue growth factor and integrin-linked kinase in high glucose-induced phenotypic alterations of podocytes.
Dai HY; Zheng M; Lv LL; Tang RN; Ma KL; Liu D; Wu M; Liu BC
J Cell Biochem; 2012 Jan; 113(1):293-301. PubMed ID: 21913214
[TBL] [Abstract][Full Text] [Related]
11. Mesenchymal stem cells ameliorate podocyte injury and proteinuria in a type 1 diabetic nephropathy rat model.
Wang S; Li Y; Zhao J; Zhang J; Huang Y
Biol Blood Marrow Transplant; 2013 Apr; 19(4):538-46. PubMed ID: 23295166
[TBL] [Abstract][Full Text] [Related]
12. Emodin mitigates podocytes apoptosis induced by endoplasmic reticulum stress through the inhibition of the PERK pathway in diabetic nephropathy.
Tian N; Gao Y; Wang X; Wu X; Zou D; Zhu Z; Han Z; Wang T; Shi Y
Drug Des Devel Ther; 2018; 12():2195-2211. PubMed ID: 30034224
[TBL] [Abstract][Full Text] [Related]
13. Effects of angiotensin receptor blocker on phenotypic alterations of podocytes in early diabetic nephropathy.
Dai HY; Zheng M; Tang RN; Ni J; Ma KL; Li Q; Liu BC
Am J Med Sci; 2011 Mar; 341(3):207-14. PubMed ID: 21326079
[TBL] [Abstract][Full Text] [Related]
14. Astragalus membranaceus and Panax notoginseng, the Novel Renoprotective Compound, Synergistically Protect against Podocyte Injury in Streptozotocin-Induced Diabetic Rats.
Zhai R; Jian G; Chen T; Xie L; Xue R; Gao C; Wang N; Xu Y; Gui D
J Diabetes Res; 2019; 2019():1602892. PubMed ID: 31179338
[TBL] [Abstract][Full Text] [Related]
15. Role of MiR-155 Signal Pathway in Regulating Podocyte Injury Induced by TGF-β1.
Lin X; Zhen X; Huang H; Wu H; You Y; Guo P; Gu X; Yang F
Cell Physiol Biochem; 2017; 42(4):1469-1480. PubMed ID: 28719898
[TBL] [Abstract][Full Text] [Related]
16. [Triptolide inhibits NLRP3 inflammasome activation and ameliorates podocyte epithelial-mesenchymal transition induced by high glucose].
Wu W; Liu BH; Wan YG; Sun W; Liu YL; Wang WW; Fang QJ; Tu Y; Yee HY; Yuan CC; Wan ZY
Zhongguo Zhong Yao Za Zhi; 2019 Dec; 44(24):5457-5464. PubMed ID: 32237395
[TBL] [Abstract][Full Text] [Related]
17. Protective effects of tacrolimus on podocytes in early diabetic nephropathy in rats.
Peng T; Chang X; Wang J; Zhen J; Yang X; Hu Z
Mol Med Rep; 2017 May; 15(5):3172-3178. PubMed ID: 28339051
[TBL] [Abstract][Full Text] [Related]
18. [Low dose of triptolide ameliorates podocyte epithelial-mesenchymal transition induced by high dose of D-glucose via inhibiting Wnt3α/β-catenin signaling pathway activation].
Shi G; Wu W; Wan YG; Hex HW; Tu Y; Han WB; Liu BH; Liu YL; Wan ZY
Zhongguo Zhong Yao Za Zhi; 2018 Jan; 43(1):139-146. PubMed ID: 29552824
[TBL] [Abstract][Full Text] [Related]
19. MYDGF attenuates podocyte injury and proteinuria by activating Akt/BAD signal pathway in mice with diabetic kidney disease.
He M; Li Y; Wang L; Guo B; Mei W; Zhu B; Zhang J; Ding Y; Meng B; Zhang L; Xiang L; Dong J; Liu M; Xiang L; Xiang G
Diabetologia; 2020 Sep; 63(9):1916-1931. PubMed ID: 32588068
[TBL] [Abstract][Full Text] [Related]
20. Selective phosphodiesterase-5 (PDE-5) inhibitor vardenafil ameliorates renal damage in type 1 diabetic rats by restoring cyclic 3',5' guanosine monophosphate (cGMP) level in podocytes.
Fang L; Radovits T; Szabó G; Mózes MM; Rosivall L; Kökény G
Nephrol Dial Transplant; 2013 Jul; 28(7):1751-61. PubMed ID: 23203993
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
